1. COVID-19 threatens M&A already in process— Physician survey shows widespread concern about access to testing and medical supplies for COVID— Novartis cancels $1B generics sale — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Therapeutic openings?

Discussion in 'Gilead Sciences' started by anonymous, Nov 13, 2019 at 12:33 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Just wondering if all the new openings are for the rheumatology JAK drug :)
     

  2. anonymous

    anonymous Guest


    Don’t you mean the jack off drug? Good luck breaking into a market with 15 competitors.
     
  3. anonymous

    anonymous Guest

    Openings are in HIV. The JAK will be a good drug- data on par with Abbive. Yes last to launch.
     
  4. anonymous

    anonymous Guest

    I heard the JAK off jobs going mainly to internal candidates. Moving people over from Hep C.
     
  5. anonymous

    anonymous Guest

    Expansion in the hiv division? Why?? They want two per territory?
     
  6. anonymous

    anonymous Guest

    Can anyone give some insight into the base salary for the HIV division reps? Thank you.
     
  7. anonymous

    anonymous Guest

    Only hiring internally.
     
  8. anonymous

    anonymous Guest

    so did the crazy ass manager for HCV in Boston lose another rep? Looks like he’s lost a bunch over the past year
     
  9. anonymous

    anonymous Guest

    HD has four asshat managers who lead with fear and intimidation - Kev, Scotty, Brian and Monica. No one trusts them and the likelihood of a larger scale law suit is looming.
     
  10. anonymous

    anonymous Guest


    All are psychopaths who HR covers for